KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:AIMT
Delisted

Aimmune Therapeutics Stock Price (Quote)

$34.49
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $34.49 $34.49 Friday, 27th May 2022 AIMT stock ended at $34.49. During the day the stock fluctuated 0% from a day low at $34.49 to a day high of $34.49.
90 days $34.49 $34.49
52 weeks $34.49 $34.49

Historical Aimmune Therapeutics prices

Date Open High Low Close Volume
Sep 21, 2020 $34.35 $34.38 $34.28 $34.32 1 502 738
Sep 18, 2020 $34.29 $34.48 $34.25 $34.30 4 291 970
Sep 17, 2020 $34.29 $34.31 $34.28 $34.29 1 225 215
Sep 16, 2020 $34.34 $34.34 $34.27 $34.31 1 280 976
Sep 15, 2020 $34.27 $34.32 $34.25 $34.31 2 598 243
Sep 14, 2020 $34.22 $34.32 $34.21 $34.31 1 948 145
Sep 11, 2020 $34.18 $34.23 $34.18 $34.20 1 265 536
Sep 10, 2020 $34.19 $34.22 $34.17 $34.19 1 254 607
Sep 09, 2020 $34.19 $34.21 $34.17 $34.18 1 130 231
Sep 08, 2020 $34.20 $34.24 $34.12 $34.17 2 057 078
Sep 04, 2020 $34.22 $34.26 $34.16 $34.22 2 750 301
Sep 03, 2020 $34.22 $34.27 $34.14 $34.23 4 780 999
Sep 02, 2020 $34.20 $34.21 $34.17 $34.19 3 954 207
Sep 01, 2020 $34.20 $34.27 $34.17 $34.19 9 180 279
Aug 31, 2020 $34.21 $34.28 $34.15 $34.22 44 642 326
Aug 28, 2020 $11.99 $12.68 $11.82 $12.60 1 894 367
Aug 27, 2020 $12.35 $12.50 $11.95 $11.99 1 460 515
Aug 26, 2020 $12.72 $12.99 $12.34 $12.38 672 273
Aug 25, 2020 $12.50 $12.86 $12.37 $12.76 788 943
Aug 24, 2020 $12.55 $12.97 $12.36 $12.48 875 561
Aug 21, 2020 $12.84 $13.02 $12.46 $12.52 1 022 164
Aug 20, 2020 $13.19 $13.41 $12.76 $12.94 932 193
Aug 19, 2020 $13.60 $13.68 $13.30 $13.30 658 702
Aug 18, 2020 $13.95 $14.02 $13.56 $13.61 683 012
Aug 17, 2020 $13.64 $14.09 $13.44 $13.88 863 143
Click to get the best stock tips daily for free!

About Aimmune Therapeutics

Aimmune Therapeutics Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its Characterized Oral Desensitization Immunotherapy includes AR101, a product in Phase 3 registration trial for the treatment of peanut allergy in children and adults. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. ... AIMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT